This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Large pharmaceuticalcompanies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. Can pharma tariffs “Make America Manufacture Again”? ASOs accounted for more than half ($3.54
Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceuticalcompany ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.
More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceuticalcompanies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US. Can pharma tariffs “Make America Manufacture Again”?
Zentiva Group has entered into a licence and supply agreement with pharmaceuticalcompany Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets. Credit: Zentiva Group, a.s.
The initiative comes at a crucial time, as British pharmaceuticalcompanies are significantly increasing their investments in the United States. Outlaid via the Life Sciences Innovative Manufacturing Fund (LSMIF), the investment will aim to expand the UK’s manufacturing capabilities and supply chain security.
The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceuticalcompanies to invest in the country. Give your business an edge with our leading industry insights.
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceuticalcompanies, the insurancecompanies, all make money by keeping us sick. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Katarina Zahedi, pharma analyst at GlobalData, comments: “These investments reflect a growing trend among pharmaceuticalcompanies to bolster domestic operations in response to geopolitical pressures and potential tariffs on imported pharmaceuticals.” Can pharma tariffs “Make America Manufacture Again”?
It feels like in the US, pharmaceuticalcompanies are capitalising on people’s frustration and desperation to lose weight.” Mochi Health recently announced insurance-based plans, new offerings that are an optional upgrade to existing plans. Give your business an edge with our leading industry insights.
While most use cases remain theoretical, early-stage collaborations between quantum computing companies and pharmaceuticalcompanies are exploring how quantum platforms might enhance protein modelling, molecular docking and energy-state simulations. Give your business an edge with our leading industry insights.
He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceuticalcompanies. Can pharma tariffs “Make America Manufacture Again”? The health secretary pointed to historical evidence for this, including an investigation from over 20 years ago.
Other countries from outside the EU and international organisations such as pharmaceuticalcompanies will be able to apply to join HealthData@EU for secondary use in March 2034. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceuticalcompanies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Can pharma tariffs “Make America Manufacture Again”? Stay proactive with real-time data and expert analysis.
Vaccine R&D stagnation likely Although ACIP recommendations are separate from the US Food and Drug Administration (FDA)’s approvals, national immunisation recommendation provides a key pillar on which to guide pipeline development for a pharmaceuticalcompany. Can pharma tariffs “Make America Manufacture Again”?
In addition to Ireland, India and China are also major suppliers of active pharmaceutical ingredients to the US, with major contract manufacturing organisations (CMOs) such as WuXi Biologics that have large plants in China. Give your business an edge with our leading industry insights.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content